| Literature DB >> 30879165 |
Erin Morgan1, John T Gamble2, Martin C Pearce2, Daniel J Elson2, Robert L Tanguay2,3,4, Siva Kumar Kolluri2,3,4, Norbert O Reich5.
Abstract
Although new cancer therapeutics are discovered at a rapid pace, lack of effective means of delivery and cancer chemoresistance thwart many of the promising therapeutics. We demonstrate a method that confronts both of these issues with the light-activated delivery of a Bcl-2 functional converting peptide, NuBCP-9, using hollow gold nanoshells. This approach has shown not only to increase the efficacy of the peptide 30-fold in vitro but also has shown to reduce paclitaxel resistant H460 lung xenograft tumor growth by 56.4%.Entities:
Keywords: Apoptosis; Bcl-2; Hollow gold nanoshells; NuBCP; Peptide delivery; Resistant cancer
Mesh:
Substances:
Year: 2019 PMID: 30879165 PMCID: PMC8918063 DOI: 10.1007/s10495-019-01531-1
Source DB: PubMed Journal: Apoptosis ISSN: 1360-8185 Impact factor: 4.677